Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Haber

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|August 21, 2012
Portal hypertension in children and young adults with biliary atresiaBenjamin L Shneider, Bob Abel, Barbara Haber, et al.
Pediatrics|August 15, 2012
Efficacy of fat-soluble vitamin supplementation in infants with biliary atresiaBenjamin L Shneider, John C Magee, Jorge A Bezerra, et al.
Hepatology (Baltimore, Md.)|October 27, 2005
Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokineticsRegino P González-Peralta, Deirdre A Kelly, Barbara Haber, et al.
Hepatology (Baltimore, Md.)|October 23, 2016
Short-duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trialEric Lawitz, Fred Poordad, Julio A Gutierrez, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 27, 2009
Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomesJames R Rodrigue, William Balistreri, Barbara Haber, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2025
Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b studyAndreas H Groll, Lara Danziger-Isakov, Aharon Gefen, et al.
Hepatology (Baltimore, Md.)|March 4, 2017
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III StudyChristophe Hézode, Massimo Colombo, Marc Bourlière, et al.
Hepatology (Baltimore, Md.)|March 3, 2012
Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trialMaureen M Jonas, William Balistreri, Regino P Gonzalez-Peralta, et al.
Hepatology (Baltimore, Md.)|January 2, 2008
Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C TrialZachary D Goodman, Hala R Makhlouf, Lea Liu, et al.
Gastroenterology|October 11, 2016
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C InfectionPaul Kwo, Edward J Gane, Cheng-Yuan Peng, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Pediatric Gastroenterology and Nutrition|August 21, 2012
Portal hypertension in children and young adults with biliary atresiaBenjamin L Shneider, Bob Abel, Barbara Haber, et al.
Pediatrics|August 15, 2012
Efficacy of fat-soluble vitamin supplementation in infants with biliary atresiaBenjamin L Shneider, John C Magee, Jorge A Bezerra, et al.
Hepatology (Baltimore, Md.)|October 27, 2005
Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokineticsRegino P González-Peralta, Deirdre A Kelly, Barbara Haber, et al.
Hepatology (Baltimore, Md.)|October 23, 2016
Short-duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trialEric Lawitz, Fred Poordad, Julio A Gutierrez, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 27, 2009
Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomesJames R Rodrigue, William Balistreri, Barbara Haber, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2025
Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b studyAndreas H Groll, Lara Danziger-Isakov, Aharon Gefen, et al.
Hepatology (Baltimore, Md.)|March 4, 2017
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III StudyChristophe Hézode, Massimo Colombo, Marc Bourlière, et al.
Hepatology (Baltimore, Md.)|March 3, 2012
Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trialMaureen M Jonas, William Balistreri, Regino P Gonzalez-Peralta, et al.
Hepatology (Baltimore, Md.)|January 2, 2008
Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C TrialZachary D Goodman, Hala R Makhlouf, Lea Liu, et al.
Gastroenterology|October 11, 2016
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C InfectionPaul Kwo, Edward J Gane, Cheng-Yuan Peng, et al.
Pageof 4